Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 430

1.

Hot joints: myth or reality? A thermographic joint assessment of inflammatory arthritis patients.

Jones B, Hassan I, Tsuyuki RT, Dos Santos MF, Russell AS, Yacyshyn E.

Clin Rheumatol. 2018 Apr 20. doi: 10.1007/s10067-018-4108-0. [Epub ahead of print]

PMID:
29679167
2.

Long-term evaluation of a Canadian back pain mass media campaign.

Suman A, Bostick GP, Schopflocher D, Russell AS, Ferrari R, Battié MC, Hu R, Buchbinder R, Gross DP.

Eur Spine J. 2017 Sep;26(9):2467-2474. doi: 10.1007/s00586-017-5249-6. Epub 2017 Aug 3.

PMID:
28776132
3.

Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice.

Gladman DD, Poulin Y, Adams K, Bourcier M, Barac S, Barber K, Chandran V, Dutz J, Flanagan C, Gooderham MJ, Gulliver WP, Ho VC, Hong CH, Karsh J, Khraishi MM, Lynde CW, Papp KA, Rahman P, Rohekar S, Rosen CF, Russell AS, Vender RB, Yeung J, Ziouzina O, Zummer M.

J Rheumatol. 2017 Apr;44(4):519-534. doi: 10.3899/jrheum.161473.

PMID:
28604347
4.

Multi-omics Based Identification of Specific Biochemical Changes Associated With PfKelch13-Mutant Artemisinin-Resistant Plasmodium falciparum.

Siddiqui G, Srivastava A, Russell AS, Creek DJ.

J Infect Dis. 2017 May 1;215(9):1435-1444. doi: 10.1093/infdis/jix156.

PMID:
28368494
5.

2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B.

Semin Arthritis Rheum. 2016 Dec;46(3):319-329. doi: 10.1016/j.semarthrit.2016.08.012. Epub 2016 Aug 30.

PMID:
27916278
6.

Effort Testing and Symptom Exaggeration Testing Are Essential in Assessing Patients with Fibromyalgia for Disability.

Ferrari R, Russell AS.

J Rheumatol. 2016 Nov;43(11):2077. No abstract available.

PMID:
27803346
7.

Comparison of Physician-Based and Patient-Based Criteria for the Diagnosis of Fibromyalgia.

Wolfe F, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Jon Russell I, Walitt B.

Arthritis Care Res (Hoboken). 2016 May;68(5):652-9. doi: 10.1002/acr.22742.

8.

Pain mystery score beliefs: a comparison of fibromyalgia and rheumatoid arthritis.

Ferrari R, Russell AS.

Int J Rheumatol. 2014;2014:593507. doi: 10.1155/2014/593507. Epub 2014 Dec 9.

9.

Fibromyalgia and physical trauma: the concepts we invent.

Wolfe F, Häuser W, Walitt BT, Katz RS, Rasker JJ, Russell AS.

J Rheumatol. 2014 Sep;41(9):1737-45. doi: 10.3899/jrheum.140268. Epub 2014 Aug 1. Review.

PMID:
25086080
10.

Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended study.

Westhovens R, Kremer JM, Emery P, Russell AS, Alten R, Barré E, Dougados M.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4):553-62. Epub 2014 Jul 8.

PMID:
25005467
11.

Prevalence of primary hyperparathyroidism in a referred sample of fibromyalgia patients.

Ferrari R, Russell AS.

Clin Rheumatol. 2015 Jul;34(7):1279-83. doi: 10.1007/s10067-014-2735-7. Epub 2014 Jul 3.

PMID:
24985043
12.

The challenge of indication extrapolation for infliximab biosimilars.

Feagan BG, Choquette D, Ghosh S, Gladman DD, Ho V, Meibohm B, Zou G, Xu Z, Shankar G, Sealey DC, Russell AS.

Biologicals. 2014 Jul;42(4):177-83. doi: 10.1016/j.biologicals.2014.05.005. Epub 2014 Jun 21. Review.

13.

Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials.

Majumdar SR, McAlister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA, Russell AS, Rowe BH.

Osteoporos Int. 2014 Sep;25(9):2173-9. doi: 10.1007/s00198-014-2728-z. Epub 2014 May 7.

PMID:
24803330
14.

Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial.

Kremer JM, Peterfy C, Russell AS, Emery P, Abud-Mendoza C, Sibilia J, Becker JC, Westhovens R, Genant HK.

J Rheumatol. 2014 Jun;41(6):1077-87. doi: 10.3899/jrheum.130263. Epub 2014 May 1.

15.

Perceived injustice in fibromyalgia and rheumatoid arthritis.

Ferrari R, Russell AS.

Clin Rheumatol. 2014;33(10):1501-7. doi: 10.1007/s10067-014-2552-z. Epub 2014 Mar 4.

PMID:
24584485
16.

Canadian estimates of health care utilization costs for rheumatoid arthritis patients with and without therapy with biologic agents.

Ohinmaa AE, Thanh NX, Barnabe C, Martin L, Russell AS, Barr SG, Maksymowych WP.

Arthritis Care Res (Hoboken). 2014 Sep;66(9):1319-27. doi: 10.1002/acr.22293.

17.

Pulmonary delivery of an ultra-fine oxytocin dry powder formulation: potential for treatment of postpartum haemorrhage in developing countries.

Prankerd RJ, Nguyen TH, Ibrahim JP, Bischof RJ, Nassta GC, Olerile LD, Russell AS, Meiser F, Parkington HC, Coleman HA, Morton DA, McIntosh MP.

PLoS One. 2013 Dec 23;8(12):e82965. doi: 10.1371/journal.pone.0082965. eCollection 2013.

18.

The number needed to offend: a cross-sectional study of potential offensiveness of rheumatic diagnostic labels.

Castillo-Ortiz JD, Russell AS, Davis P, Vargas-Serafin CO, Ramirez-Gomez A, Aceves-Avila FJ, De la Mora-Molina H, Gonzalez-Leija ME, Pacheco-Lorenzo R, Ramos-Remus C.

Clin Rheumatol. 2014 Apr;33(4):561-6. doi: 10.1007/s10067-013-2407-z. Epub 2013 Oct 10.

PMID:
24114394
19.

A questionnaire using the modified 2010 American College of Rheumatology criteria for fibromyalgia: specificity and sensitivity in clinical practice.

Ferrari R, Russell AS.

J Rheumatol. 2013 Sep;40(9):1590-5. doi: 10.3899/jrheum.130367. Epub 2013 Jul 1.

PMID:
23818707
20.

QuantiFERON testing for cell-mediated immunity to cytomegalovirus in patients with rheumatoid arthritis receiving abatacept and other DMARD therapy.

Russell AS, Lisboa L, Santos MF, Kumar D, Humar A.

Clin Rheumatol. 2013 Nov;32(11):1657-9. doi: 10.1007/s10067-013-2298-z. Epub 2013 Jun 11. No abstract available.

PMID:
23754242
21.

A biologic pharmacosurveillance program for rheumatoid arthritis: a single-center experience.

Russell AS, Mallon C, Conner-Spady B, Maksymowych W.

Clin Rheumatol. 2013 Jun;32(6):875-7. doi: 10.1007/s10067-013-2177-7. Epub 2013 Feb 2.

PMID:
23377198
22.

Cost-effectiveness of osteoporosis interventions for 'incidental' vertebral fractures.

Majumdar SR, Lier DA, McAlister FA, Rowe BH, Siminoski K, Hanley DA, Russell AS, Johnson JA.

Am J Med. 2013 Feb;126(2):169.e9-17. doi: 10.1016/j.amjmed.2012.10.009.

PMID:
23331449
23.

Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee.

Maksymowych WP, Russell AS, Chiu P, Yan A, Jones N, Clare T, Lambert RG.

Arthritis Res Ther. 2012 Oct 4;14(5):R206. doi: 10.1186/ar4044.

24.

Palindromic rheumatism: a pre-rheumatoid arthritis state?

Katz SJ, Russell AS.

J Rheumatol. 2012 Oct;39(10):1912-3. doi: 10.3899/jrheum.120995. No abstract available.

PMID:
23028026
25.

Interventions to increase osteoporosis treatment in patients with 'incidentally' detected vertebral fractures.

Majumdar SR, McAlister FA, Johnson JA, Bellerose D, Siminoski K, Hanley DA, Qazi I, Lier DA, Lambert RG, Russell AS, Rowe BH.

Am J Med. 2012 Sep;125(9):929-36. doi: 10.1016/j.amjmed.2012.02.021.

PMID:
22938928
26.

Subsequent entry biologics/biosimilars: a viewpoint from Canada.

Russell AS, Ahluwalla V, Barnabe C, Jamal S, Offer RC, Olszynski WP, Shojania K, Haraoui B.

Clin Rheumatol. 2012 Sep;31(9):1289-92. doi: 10.1007/s10067-012-2066-5. Epub 2012 Aug 26. Review.

PMID:
22923182
27.

Whiplash: nothing to lose sleep over.

Ferrari R, Russell AS.

J Rheumatol. 2012 Mar;39(3):655; author reply 656-7. doi: 10.3899/jrheum.110970. No abstract available.

PMID:
22383355
28.

Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.

Nanji JA, Choi M, Ferrari R, Lyddell C, Russell AS.

J Rheumatol. 2012 Apr;39(4):707-11. doi: 10.3899/jrheum.110818. Epub 2012 Feb 15.

PMID:
22337235
29.

Fatigue and quality of sleep in patients with immune-mediated inflammatory disease.

Graff LA, Walker JR, Russell AS, Bissonnette R, Bernstein CN.

J Rheumatol Suppl. 2011 Nov;88:36-42. doi: 10.3899/jrheum.110902. Review.

PMID:
22045977
30.

The influence of uveitis on patients with immune-mediated inflammatory disease.

Rosenbaum JT, Russell AS, Guenther LC, El-Gabalawy H.

J Rheumatol Suppl. 2011 Nov;88:26-30. doi: 10.3899/jrheum.110907. Review.

PMID:
22045975
31.

Quality of life issues in pediatric immune-mediated inflammatory disease.

Duffy CM, Wells GA, Russell AS, Haraoui B.

J Rheumatol Suppl. 2011 Nov;88:20-5. doi: 10.3899/jrheum.110905. Review.

PMID:
22045974
32.

Quality of life in patients with immune-mediated inflammatory diseases.

Russell AS, Gulliver WP, Irvine EJ, Albani S, Dutz JP.

J Rheumatol Suppl. 2011 Nov;88:7-19. doi: 10.3899/jrheum.110899. Review.

PMID:
22045973
33.

Validity of quality of life measurement tools--from generic to disease-specific.

Wells GA, Russell AS, Haraoui B, Bissonnette R, Ware CF.

J Rheumatol Suppl. 2011 Nov;88:2-6. doi: 10.3899/jrheum.110906.

PMID:
22045972
34.

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial.

Kremer JM, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Westhovens R, Li T, Zhou X, Becker JC, Aranda R, Peterfy C, Genant HK.

Ann Rheum Dis. 2011 Oct;70(10):1826-30. doi: 10.1136/ard.2010.139345.

35.

Collisions and chronic pain: The solution is finding the problem. Comment on the article by Jones et al.

Ferrari R, Russell AS.

Arthritis Care Res (Hoboken). 2011 Oct;63(10):1495-6. doi: 10.1002/acr.20535. No abstract available.

36.

Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.

Katz SJ, Russell AS.

Curr Opin Rheumatol. 2011 May;23(3):278-81. doi: 10.1097/BOR.0b013e32834456bf. Review.

PMID:
21448012
37.

Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB.

J Rheumatol. 2011 Jun;38(6):1113-22. doi: 10.3899/jrheum.100594. Epub 2011 Feb 1.

PMID:
21285161
38.

Anti-tumor necrosis factor therapies in immune-mediated rheumatic diseases. Other observations from the clinic.

Russell AS, Rosenbaum JT.

J Rheumatol Suppl. 2010 May;85:53-62. doi: 10.3899/jrheum.091465. Review.

PMID:
20436165
39.

From Bedside to Bench: the Role of Anti-Tumor Necrosis Factor Agents in the Management of Immune-Mediated Inflammatory Diseases.

Haraoui B, Russell AS, Keystone EC.

J Rheumatol Suppl. 2010 May;85:1. doi: 10.3899/jrheum.091460. No abstract available.

PMID:
20436160
40.

Tennis leg--a new variant of an old syndrome.

Russell AS, Crowther S.

Clin Rheumatol. 2011 Jun;30(6):855-7. doi: 10.1007/s10067-011-1681-x. Epub 2011 Jan 18. Review.

PMID:
21243387
41.

Effect of a symptom diary on symptom frequency and intensity in healthy subjects.

Ferrari R, Russell AS.

J Rheumatol. 2010 Nov;37(11):2387-9. doi: 10.3899/jrheum.100513. Epub 2010 Oct 1.

PMID:
20889603
42.

Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture.

Majumdar SR, Lier DA, Rowe BH, Russell AS, McAlister FA, Maksymowych WP, Hanley DA, Morrish DW, Johnson JA.

Osteoporos Int. 2011 Jun;22(6):1799-808. doi: 10.1007/s00198-010-1412-1. Epub 2010 Sep 29.

PMID:
20878389
43.

Correlations between coping styles and symptom expectation for rheumatoid arthritis.

Ferrari R, Russell AS.

Clin Rheumatol. 2010 Dec;29(12):1445-8. doi: 10.1007/s10067-010-1551-y. Epub 2010 Aug 17.

PMID:
20714764
44.

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB.

Arthritis Care Res (Hoboken). 2010 May;62(5):600-10. doi: 10.1002/acr.20140.

45.

Correlations between coping styles and symptom expectation for whiplash injury.

Ferrari R, Russell AS.

Clin Rheumatol. 2010 Nov;29(11):1245-9. doi: 10.1007/s10067-010-1443-1. Epub 2010 Apr 10.

PMID:
20383547
46.

Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study.

Majumdar SR, Johnson JA, Bellerose D, McAlister FA, Russell AS, Hanley DA, Garg S, Lier DA, Maksymowych WP, Morrish DW, Rowe BH.

Osteoporos Int. 2011 Jan;22(1):223-30. doi: 10.1007/s00198-010-1212-7. Epub 2010 Apr 1.

PMID:
20358359
47.

Evaluation of a Canadian back pain mass media campaign.

Gross DP, Russell AS, Ferrari R, Battié MC, Schopflocher D, Hu R, Waddell G, Buchbinder R.

Spine (Phila Pa 1976). 2010 Apr 15;35(8):906-13. doi: 10.1097/BRS.0b013e3181c91140.

PMID:
20308943
48.

Expectations in rheumatoid arthritis.

Ferrari R, Russell AS.

J Psychosom Res. 2010 Mar;68(3):311-2. doi: 10.1016/j.jpsychores.2009.12.002. Epub 2010 Jan 8. No abstract available.

PMID:
20159219
49.

Leveling the field in the treatment of rheumatoid arthritis with biologic therapies: equal access for equal efficacy.

Russell AS, Olszynski WP, Davison KS, Koehn C, Haraoui B.

Clin Rheumatol. 2010 Mar;29(3):233-9. doi: 10.1007/s10067-009-1338-1. Epub 2009 Dec 29. Review. No abstract available.

PMID:
20039183
50.

Relative efficacies: antimalarials to abatacept - the choice is ours.

Russell AS.

J Rheumatol Suppl. 2009 Jun;82:17-24. doi: 10.3899/jrheum.090127. Review.

PMID:
19509326

Supplemental Content

Loading ...
Support Center